Table 6: Mean percent of change of the remaining parameters after than before treatment among the studied patients with colorectal cancer receiving chemotherapy (treated with recombinant human lactoferrin and not).

Parameters Mean percent of change (%) among the studied patients with colorectal cancer receiving chemotherapy ()-test
Group 1
(treated with lactoferrin)
()
Group 2
(not treated with lactoferrin)
()

CEA (ng/mL):
 Range↓98.02–↓20.83↓89.53–400.003.7910.001*
 Mean ± SD↓−47.45 ± 20.9195.92 ± 144.93
RBC (×106/microL):
 Range5.72–15.20↓11.59–7.4110.0150.0001*
 Mean ± SD11.65 ± 2.15↓−11.65 ± 2.15
Hemoglobin (HB) (g/dL):
 Range13.91–24.72↓23.65–9.648.4560.0001*
 Mean ± SD17.91 ± 2.76↓−3.75 ± 9.53
WBCs (×103/mm3):
 Range↓29.00–40.68↓26.82–18.894.1520.0001*
 Mean ± SD21.51 ± 18.27↓−1.40 ± 11.09
Platelets (×103/mm3):
 Range3.43–21.94↓39.05–8.817.2220.0001*
 Mean ± SD18.51 ± 4.56↓−10.38 ± 14.81
Neutrophil (%):
 Range20.97–28.57↓19.67–14.6311.0920.0001*
 Mean ± SD26.31 ± 2.11↓−1.08 ± 9.33
BUN (mg/dL):
 Range↓53.00–↓16.67↓19.44–57.895.8580.0001*
 Mean ± SD↓−28.18 ± 10.477.92 ± 21.44
Serum creatinine (mg/dL):
 Range↓40.00–100↓16.67–70.731.5960.122
 Mean ± SD↓−5.24 ± 37.1513.03 ± 24.20
AST (IU/L):
 Range↓62.07–↓17.60↓53.85–89.873.7570.001*
 Mean ± SD↓−27.50 ± 15.134.63 ± 29.46
ALT (IU/L):
 Range↓32.23–155.56−23.19–28.710.7550.457
 Mean ± SD↓−5.66 ± 46.833.97 ± 15.96

Note: *significant ().